Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
GlobeNewswire
*COPENHAGEN, Denmark, April 2, 2024* – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS^®, the only FDA-approved..
*COPENHAGEN, Denmark, April 2, 2024* – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS^®, the only FDA-approved..
*U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ*^*®*
·..
*COPENHAGEN, Denmark, November 16, 2023 *– Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the..